Page last updated: 2024-10-24

cefuroxime and Anemia, Sickle Cell

cefuroxime has been researched along with Anemia, Sickle Cell in 2 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Prosser, DP1
Gompels, M1
Rogers, ZR1
Morrison, RA1
Vedro, DA1
Buchanan, GR1

Other Studies

2 other studies available for cefuroxime and Anemia, Sickle Cell

ArticleYear
Anaphylactic shock due to cefuroxime in a patient taking penicillin prophylaxis.
    Paediatric anaesthesia, 2002, Volume: 12, Issue:1

    Topics: Adolescent; Anaphylaxis; Anemia, Sickle Cell; Antibiotic Prophylaxis; Cefuroxime; Cephalosporins; Fe

2002
Outpatient management of febrile illness in infants and young children with sickle cell anemia.
    The Journal of pediatrics, 1990, Volume: 117, Issue:5

    Topics: Age Factors; Anemia, Sickle Cell; Anti-Bacterial Agents; Bacterial Infections; Body Temperature; Cef

1990